Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Toxicon. 2011 Sep 12;58(8):672–680. doi: 10.1016/j.toxicon.2011.09.001

Fig. 3.

Fig. 3

Purification of Crassipeptide cce9a. Samples were fractionated on an analytical C18 HPLC column and eluted with gradients of acetonitrile in 0.1% TFA indicated by the dashed lines. The elution profiles at 220nm (blue), 254 nm (red) and 280 nm (green) are shown. The neuroactive fraction is marked with an arrow. The pure peptide (inset) was isolated by subfractionation of the active fraction in A using a shallower linear gradient. The peptide was named cce9a following turripeptide nomenclature (Heralde et al., 2008).